Cells For Transient Expression And Uses Thereof
AssigneeMedlmmune, LLC
InventorsOlalekan Daramola, Gregory Dean, Diane Hatton, Jessica Stevenson
Life of this patent
Estimating the term…
Loading patent…
AssigneeMedlmmune, LLC
InventorsOlalekan Daramola, Gregory Dean, Diane Hatton, Jessica Stevenson
Estimating the term…
This invention relates to the transient expression of heterologous polypeptides in mammalian cell lines. Specifically it relates to an expression-enhanced cell line derived from a parent cell line, the expression-enhanced cell line comprising nucleic acid encoding Epstein-Barr Virus Nuclear Antigen 1 or a functional derivative, analogue, or variant thereof; and further comprising: (a) a nucleic acid encoding an exogenous glutamine synthetase; (b) a nucleic acid encoding an endogenous glutamine synthetase, wherein the endogenous glutamine is arranged to have enhanced enzymatic activity and/or enhanced expression relative to the parent cell line under comparable conditions; or (c) both (a) and (b).
An expression-enhanced cell line derived from a parent cell line, the expression-enhanced cell line comprising nucleic acid encoding Epstein-Barr Virus Nuclear Antigen 1 or a functional derivative, analogue, or variant thereof;
13-14. (canceled)
18-49. (canceled)
51-52. (canceled)
(canceled)
Dependencies are inferred from the claim text.